229970-68-7CC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1NYGNSHYRMOVKKSL-UHFFFAOYSA-N229970-68-7DTXSID701350124안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
일반 설명A Certified Spiking Solution suitable for use in retigabine testing methods by LC/MS or GC/MS for applications in clinical toxicology, medication monitoring, urine drug testing, pharmaceutical research, or forensic analysis. N-Acetylretigabine is the primary urinary metabolite of retigabine, a new antiepileptic drug developed for treatment of partial seizures. Also known as ezogabine, the drug is marketed under the trade names Potiga in the US and Trobalt in the EU.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…